Joseph Baroldi, EVP, Chief Business Officer at IONIS PHARMACEUTICALS INC (IONS), sold 6,659 shares at $80.41 ($531K) on 2026-03-03, disclosed to the SEC on 2026-03-05.
Scheduled sale ($531k) by EVP, Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $79.36 | 4,096 | $325K | 61.2% |
| 2 | $80.41 | 2,088 | $168K | 31.6% |
| 3 | $81.01 | 36 | $3K | 0.5% |
| 4 | $80.00 | 201 | $16K | 3.0% |
| 5 | $80.00 | 238 | $19K | 3.6% |
| Total | $79.74 avg | 6,659 |
| $531K |
| 100% |
| Filing → |
| IONS | SELL | 2026-04-17 | $419K | — | Filing → |
| IONS | SELL | 2026-02-02 | $439K | — | Filing → |
| IONS | SELL | 2026-01-20 | $610K | — | Filing → |